MEDEA Biopharma
MEDEA Biopharma is a biopharmaceutical company founded in 2022, specializing in developing high-precision antimicrobials based on bacteriophages to target and eliminate harmful bacteria. Their mission is to revolutionize bacterial infection treatment and address antibiotic resistance by harnessing the full potential of phages for novel antimicrobial compounds. They validate bacterial targets, discover effective bacteriophages, and enable scalable tailored applications across various industries including animal health, aquaculture, and food protection.
Industries
Nr. of Employees
small (1-50)
MEDEA Biopharma
Products
Bacteriophage-based Antimicrobials
Develops antimicrobial solutions using bacteriophages to target and eliminate harmful bacteria.
Bacteriophage-based Antimicrobials
Develops antimicrobial solutions using bacteriophages to target and eliminate harmful bacteria.
Animal Health Solutions
Provides antibacterial and hygiene solutions for animals using bacteriophages.
Animal Health Solutions
Provides antibacterial and hygiene solutions for animals using bacteriophages.
Aquaculture Solutions
Offers bacteriophage-based antibacterial solutions for aquaculture.
Aquaculture Solutions
Offers bacteriophage-based antibacterial solutions for aquaculture.
Bacteriophage-based Antimicrobials
Develops antimicrobial solutions using bacteriophages to target and eliminate harmful bacteria.
Bacteriophage-based Antimicrobials
Develops antimicrobial solutions using bacteriophages to target and eliminate harmful bacteria.
Animal Health Solutions
Provides antibacterial and hygiene solutions for animals using bacteriophages.
Animal Health Solutions
Provides antibacterial and hygiene solutions for animals using bacteriophages.
Aquaculture Solutions
Offers bacteriophage-based antibacterial solutions for aquaculture.
Aquaculture Solutions
Offers bacteriophage-based antibacterial solutions for aquaculture.
Services
Phage discovery and target validation services
Discovery workflows to identify bacteriophages active against validated bacterial targets and experimental validation of target susceptibility.
Development of tailored phage applications for industry
Development and adaptation of bacteriophage-based antimicrobial modalities for specific industry sectors such as animal health, aquaculture, and plant/food protection.
Phage discovery and target validation services
Discovery workflows to identify bacteriophages active against validated bacterial targets and experimental validation of target susceptibility.
Development of tailored phage applications for industry
Development and adaptation of bacteriophage-based antimicrobial modalities for specific industry sectors such as animal health, aquaculture, and plant/food protection.
Expertise Areas
- Phage-based antimicrobial lead discovery
- Bacterial target validation
- Bacteriophage isolation and screening
- Scaling bioprocesses for biological agents
Key Technologies
- Bacteriophage-based antimicrobials
- Phage isolation and screening
- Host-range profiling assays
- Bioprocess scale-up for biologics